Investigates how disruptions in neuronal activity, network function, and protein homeostasis contribute to Alzheimer's disease. Focuses on mammalian target of rapamycin signaling and related pathways that regulate amyloid, tau, synaptic dysfunction, and potential therapeutic responses.